Detection of occult hepatitis B virus among chronic hepatitis C patientsFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 12 September 2015

References

• Ding-Shinn Chen Jia-Horng Kao Pei-Jer Chen Ming-Yang Lai Hepatitis C clinical outcomes of patients with chronic hepatitis C J Clin Microbiol 40 11 2002 4068 4071
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B. World Health Organization Fact Sheet N°204 (Revised March 2014). WHO Web site. World Health Organization, Hepatitis B. Fact sheet N°204; 2014. Available at: WHO Web site http://www.who.int/mediacentre/factsheets/fs204/en//.
   Google Scholar
• World Health Organization. Hepatitis C. World Health Organization Fact Sheet N°164 (Revised April 2014). WHO Web site. World Health Organization, Hepatitis C. Fact sheet N°164; 2014. Available at: WHO Web site http://www.who.int/mediacentre/factsheets/fs164/en//.
   Google Scholar
• S. Bowden New directions in molecular diagnostics for hepatitis B: serum and tissue-based diagnostics J Gastroenterol Hepatol 19 2004 S311 S314
   Google Scholar
• D. Shouval What is the clinical significance of the high prevalence of occult hepatitis B in US liver transplant patients with chronic hepatitis C Liver Transpl 14 2008 418 419
   PubMed Web of Science ®Google Scholar
• Z. Honarkar S.M. Alavian S. Samiee K. Saeedfar M. Baladast M.J. Ehsani Occult Hepatitis B as a cause of cryptogenic cirrhosis Hepat Mon 4 2004 155 160
   Google Scholar
• S. Mrani I. Chemin K. Menouar O. Guillaud P. Pradat G. Borghi Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C J Med Virol 79 2007 1075 1081
   PubMed Web of Science ®Google Scholar
• K. Shetty M. Hussain L. Nei K.R. Reddy A.S. Lok Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C Liver Transpl 14 2008 534 540
   PubMed Web of Science ®Google Scholar
• J. Kleiber T. Walter G. Haberhausen S. Tsaung R. Babeil M. Rosenstaus Performance Characteristics of a Quantitative, Homogeneous TaqMan RT-PCR Test for HCV RNA J Mol Diagnos 2 3 2000 158 166
   PubMed Web of Science ®Google Scholar
• F.B. Hollinger G. Sood Occult hepatitis B virus infection: a covert operation J Viral Hepat 17 2010 1 15
   PubMed Web of Science ®Google Scholar
• J.H. Kao P.J. Chen M.Y. Lai D.S. Chen Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C J Clin Microbiol 2002 4068 4071
   PubMed Web of Science ®Google Scholar
• F.B. Hollinger T.J. Liang Hepatitis B virus D.M. Knipe Fields virology 4th ed. 2001 Lippincott Williams & Wilkins Philadelphia 2971 3036
   Google Scholar
• E. Sagnelli N. Coppola C. Scolasticoc Virologic and clinical expression of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronichepatitis Hepatology 32 2000 1106 1110
   PubMed Web of Science ®Google Scholar
• J.P. Allain Occult hepatitis B virus Transfus Clin Biol 11 2004 11 25
   PubMed Web of Science ®Google Scholar
• I. Cacciola T. Pollicino G. Squadrito G. Cerenzia M.E. Orlando Occult hepatitis B. Virus infection in patients with chronic hepatitis C liverdisease N Engl J Med 341 1999 22 26
   PubMed Web of Science ®Google Scholar
• H. Yotsuyanagi Y. Shintani K. Moriya H. Fujie Virologic analysis of non-B, non-C hepatolcellular carcinoma in Japan: frequent involvement of hepatitis B virus J Infect Dis 181 2000 1920 1928
   PubMed Web of Science ®Google Scholar
• S. Ocana M.L. Casas I. Buhigas J.L. Lledo Diagnostic strategy for occult hepatitis B virus infection World J Gastroenterol 17 2011 1553 1557
   PubMed Web of Science ®Google Scholar
• L. Stuyver C. Van Geyt S. De Gendt G. Van Reybroeck F. Zoulim G. Leroux-Roels Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy J Clin Microbiol 38 2000 702 707
   PubMed Web of Science ®Google Scholar
• M. Torbenson D.L. Thomas Occult hepatitis B Lancet Infect Dis 2 8 2002 479 486
   PubMed Web of Science ®Google Scholar
• G. Raimondo T. Pollicino I. Cacciola G. Squadrito Occult hepatitis B virus infection J Hepatol 46 1 2007 160 170
   PubMed Web of Science ®Google Scholar
• M. Levast S. Larrat M.A. Thelu S. Nicod A. Plages A. Cheveau Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin J Med Virol 82 2010 747 754
   PubMed Web of Science ®Google Scholar
• M.H. Emara N.E. El-Gammal L.A. Mohamed M.M. Bahgat Occult hepatitis B infection in Egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy Virol J 7 2010 324
   PubMed Web of Science ®Google Scholar
• A. Shavakhi B. Norinayer S.A. Esteghamat M. Seghatoleslami M. Khodadustan H.M. Somi Occult hepatitis B among Iranian hepatitis C patients JRMS 14 1 2009 13 17
   Google Scholar
• S. Saravanan V. Velu S. Nandakumar V. Madhavan U. Shanmugasundaram K.G. Murugavel Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease J Microbiol Immunol Infect 42 2009 122 128
   PubMedGoogle Scholar
• H.S. Selim H.A. Abou-Donia H.A. Taha G.I. El Azab A.F. Bakry Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes Eur J Intern Med 22 2011 187 190
   PubMed Web of Science ®Google Scholar
• L. Kazemi-Shirazi D. Petermann C. Muller Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C J Hepatol 33 2000 785 790
   PubMed Web of Science ®Google Scholar
• L.F. Mariscal E. Rodriguez-Inigo J. Bartolome I. Castillo N. Ortiz-Movilla C. Navacerrada Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum J Med Virol 73 2004 177 186
   PubMed Web of Science ®Google Scholar
• G. Raimondo T. Pollicino I. Cacciola G. Squadrito Occult hepatitis B virus infection J Hepatol 46 2007 160 170
   PubMed Web of Science ®Google Scholar
• T. Pollicino G. Squadrito G. Cerenzia I. Cacciola G. Raffa A. Craxi Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection Gastroenterology 126 2004 102 110
   PubMed Web of Science ®Google Scholar
• S. Ramia A.I. Sharara M. El-Zaatari F. Ramlawi Z. Mahfoud Occult hepatitis B virus infection in Lebanese patients with chronic hepatitis C liver disease Eur J Clin Microbiol Infect Dis 27 2008 217 221
   PubMed Web of Science ®Google Scholar
• S.P. Georgiadou K. Zachou E. Rigopoulou C. Liaskos P. Mina F. Gerovasilis Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases J Viral Hepat 11 2004 358 365
   PubMed Web of Science ®Google Scholar
• C.K. Hui E. Lau H. Wu A. Monto M. Kim J.M. Luk Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection J Clin Virol 35 2006 209 218
   Web of Science ®Google Scholar
• J.R. Larrubia Occult hepatitis B virus infection: a complex entity with relevant clinical implications World J Gastroenterol 17 2011 1529 1530
   PubMed Web of Science ®Google Scholar
• Z.N. Said An overview of occult hepatitis B virus infection World J Gastroenterol 17 2011 1927 1938
   PubMed Web of Science ®Google Scholar
• P. Habibollahi S. Safari N.E. Daryani S.M. Alavian Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection Saudi J Gastroenterol 15 2009 220 224
   PubMedGoogle Scholar
• P. Schmeltzer K.E. Sherman Occult hepatitis B: clinical implications and treatment decisions Dig Dis Sci 55 2010 3328 3335
   PubMed Web of Science ®Google Scholar
• J. Samal M. Kandpal P. Vivekanandan Molecular mechanisms underlying occult hepatitis B virus infection Clin Microbiol Rev 25 2012 142 163
   PubMed Web of Science ®Google Scholar
• R. Fukuda N. Ishimura M. Niigaki S. Hamamoto S. Satoh S. Tanaka Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance J Med Virol 58 1999 201 207
   PubMed Web of Science ®Google Scholar
• W. Jilg E. Sieger R. Zachoval H. Schatzl Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus J Hepatol 23 1995 14 20
   PubMed Web of Science ®Google Scholar
• O. Kader A. Ghazal D.E. Metwally A. Elnour G. Yousif Detection of occult Hepatitis B virus infection among blood donors in Sudan J Egypt Pub Health Assoc 88 2013 14 18
   PubMedGoogle Scholar
• T. Allice F. Cerutti F. Pittaluga S. Varetto S. Gabella A. Marzano COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma J Clin Microbiol 45 2007 828 834
   PubMed Web of Science ®Google Scholar
• S. Chevaliez M. Bouvier-Alias S. Laperche J.M. Pawlotsky Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification J Clin Microbiol 46 2008 1716 1723
   PubMed Web of Science ®Google Scholar
• M. Levast S. Larrat M.A. Thelu S. Nicod A. Plages A. Cheveau Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin J Med Virol 82 2010 747 754
   PubMed Web of Science ®Google Scholar
• E. Sagnelli M. Imparato N. Coppola R. Pisapia C. Sagnelli V. Messina Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study J Med Virol 80 2008 1547 1553
   PubMed Web of Science ®Google Scholar
• E. Khattab I. Chemin I. Vuillermoz C. Vieux S. Mrani O. Guillaud Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy J Clin Virol 33 2005 150 157
   PubMed Web of Science ®Google Scholar
• K. Shetty M. Hussain L. Nei K.R. Reddy A.S. Lok Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C Liver Transpl. 14 2008 534 540
   PubMed Web of Science ®Google Scholar
• K. Fujiwara Y. Tanaka E. Orito T. Ohno T. Kato F. Sugauchi Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease J Gastroenterol Hepatol 19 2004 1343 1347
   PubMed Web of Science ®Google Scholar
• D. Candotti J.P. Allain Transfusion-transmitted hepatitis B virus infection J Hepatol 51 2009 798 809
   PubMed Web of Science ®Google Scholar
• C. Saitta P. Pontisso M.R. Brunetto S. Fargion G.B. Gaeta G.A. Niro Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy Antivir Ther 11 2006 931 934
   PubMed Web of Science ®Google Scholar
• S.D. Crockett E.B. Keeffe Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection Ann Clin Microbiol Antimicrob 4 2005 13
   PubMedGoogle Scholar
• R.S. Koff Hepatitis essentials 2011 Jones & Bartlett Publishersp.11–2
   Google Scholar
• E. Rodriguez-Inigo J. Bartolome N. Ortiz-Movilla C. Platero J.M. Lopez-Alcorocho M. Pardo Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection J Virol 79 2005 15578 15581
   PubMed Web of Science ®Google Scholar
• Y. Miura A. Shibuya S. Adachi A. Takeuchi T. Tsuchihashi T. Nakazawa Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails Hepatol Res 38 2008 546 556
   PubMed Web of Science ®Google Scholar
• P. Fabris D. Brown G. Tositti L. Bozzola M.T. Giordani P. Bevilacqua Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C J Clin Virol 29 2004 160 166
   PubMed Web of Science ®Google Scholar
• C.M. Fernandez-Rodriguez M.L. Gutierrez J.L. Lledo M.L. Casas Influence of occult hepatitis B virus infection in chronic hepatitis C outcomes World J Gastroenterol 17 2011 1558 1562
   PubMed Web of Science ®Google Scholar
• A. El-Sherif M. Abou-Shady H. Abou-Zeid A. Elwassief A. Elbahrawy Y. Ueda Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients J Gastroenterol 44 2009 359 364
   PubMed Web of Science ®Google Scholar